| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","company":"Vera Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","article_chars":305,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_ee035548e71fb959","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:16:47.580236+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt","source_event_id":"evt_985ccfd7e119","source_quality":"low","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"8f5ce775f002add4","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.5,"dates_mentioned":["2026-04-10T03:04:31.796915+00:00","20260409"],"entities":[{"asset_class":"equity","name":"Vera Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"other","information_gaps":["The cleaned article text contains only repeated 'TABLE OF CONTENTS' and no substantive DEF 14A content.","No information is provided about what changed versus any prior known state (no prior filing reference or delta details included).","No disclosed financial implications, guidance, or specific proxy items are included in the provided text.","Issuer ticker/symbol is not provided in the text."],"key_facts":["Signal indicates discovery of an SEC filing: Form DEF 14A.","Filing date provided in structured context: 2026-04-10T03:04:31.796915+00:00.","SEC filing form type provided: DEF 14A.","No additional filing contents (e.g., proposals, compensation, voting matters) are present in the provided cleaned article text."],"numeric_claims":[{"label":"SEC filing date (provided)","value":"2026-04-10T03:04:31.796915+00:00"}],"primary_claim":"Vera Therapeutics, Inc. filed Form DEF 14A on 2026-04-10 (SEC filing date shown as 2026-04-10T03:04:31.796915+00:00).","relevance_score":0.35,"sentiment":"neutral","source_quality":"low","summary":"Vera Therapeutics, Inc. filed a DEF 14A proxy statement. The provided text does not include any additional disclosed details beyond the filing identification.","topics":["SEC filing","DEF 14A","proxy statement"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Vera Therapeutics, Inc. \u00b7 Filed 20260409","ticker":"VERA","tickers":["VERA"],"title":"VERA filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1831828/0001140361-26-014002.txt"}... |